IBEX REPORTS RESULTS FOR THE SECOND QUARTER AND THE SIX MONTHS ENDED JANUARY 31, 2020
MONTRÉAL, March 26, 2020 (GLOBE NEWSWIRE) — IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported its […]
ABM INDUSTRIES PROVIDES BUSINESS UPDATE
NEW YORK, March 26, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today provided a […]
CONSTELLATION BRANDS PARTNERS WITH ITS FLAGSHIP BRANDS TO COMMIT MORE THAN $2.5 MILLION TO COVID-19 RELIEF EFFORTS
Contributes $1 million to National Restaurant Association Educational Foundation, $500K to U.S. Bartenders’ Guild, and $250K to support first respondersEstablishes […]
VBL Therapeutics Announces Positive Outcome of the Interim Analysis in the OVAL Phase 3 Ovarian Cancer Pivotal Study
OVAL independent Data Safety Monitoring Committee (DSMC) reviewed un-blinded data and determined that the study has met the interim pre-specified […]
DEBRA BRADFORD AND LAURA EASLEY NOMINATED TO JOIN TRIUMPH BANCORP BOARD OF DIRECTORS
DALLAS, March 26, 2020 (GLOBE NEWSWIRE) — Triumph Bancorp, Inc. (Nasdaq: TBK) (“the Company”) is pleased to announce that Debra […]
Angkor To Issue Shares
TORONTO, March 26, 2020 (GLOBE NEWSWIRE) — Angkor Resources Corp. (TSXV: ANK and OTC: ANKOF) (“Angkor” or “the Company”) CEO […]
PRIMORIS SERVICES CORPORATION ANNOUNCES UTILITY AWARDS VALUED OVER $35 MILLION
DALLAS, March 26, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced two […]
Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
EMERYVILLE, Calif., March 26, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and […]
Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates
CAMBRIDGE, Mass., March 26, 2020 (GLOBE NEWSWIRE) — Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative […]
Affimed Announces Participation at Upcoming Virtual Investor Conferences
Heidelberg, Germany, March 26, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
